Brief: Rovi To Proceed With Share Capital Reduction

Laboratorios Farmaceuticos Rovi

01/08/2024 07:24

Aug 1 (Reuters) - Laboratorios Farmaceuticos ROVI SA
 ROVI.MC :
    * TO PROCEED WITH SHARE CAPITAL REDUCTION THROUGH REDEMPTION
OF
TREASURY SHARES
    * SHARE CAPITAL TO BE REDUCED BY 166,823 EUROS THROUGH
REDEMPTION
OF 2.8 MILLION SHARES
    * PURPOSE OF  SHARE CAPITAL REDUCTION IS TO REDEEM TREASURY
SHARES
IN ORDER TO CONTRIBUTE TO COMPANY’S SHAREHOLDER REMUNERATION
POLICY
    * EXECUTION OF SHARE CAPITAL REDUCTION WILL BE CARRIED OUT
IN THE
SHORTEST POSSIBLE TIME
    * SHARE CAPITAL WILL BE FIXED AT 3.1 MILLION EUROS,
CORRESPONDING
TO 51.2 MILLION SHARES WITH A NOMINAL VALUE OF 0.06 EUROS EACH

Source text for Workspace:  ID:nCNM5wlnqs 
Further company coverage:  ROVI.MC 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))